<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Interleukin-5 | Katja Kero's homepage</title><link>https://katjakero.netlify.app/tags/interleukin-5/</link><atom:link href="https://katjakero.netlify.app/tags/interleukin-5/index.xml" rel="self" type="application/rss+xml"/><description>Interleukin-5</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Fri, 01 Oct 2021 00:00:00 +0000</lastBuildDate><image><url>https://katjakero.netlify.app/media/icon_hu356876048692356835.png</url><title>Interleukin-5</title><link>https://katjakero.netlify.app/tags/interleukin-5/</link></image><item><title>Interferon-γ and IL-5 associated cell-mediated immune responses to HPV16 E2 and E6 distinguish between persistent oral HPV16 infections and noninfected mucosa</title><link>https://katjakero.netlify.app/peer/paaso-interferon-2021/</link><pubDate>Fri, 01 Oct 2021 00:00:00 +0000</pubDate><guid>https://katjakero.netlify.app/peer/paaso-interferon-2021/</guid><description/></item></channel></rss>